Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The EveryLife Foundation for Rare Diseases, often associated with its founder Emil Kakkis as the Kakkis EveryLife Foundation, is a 501(c)(3) non-profit advocacy organization dedicated to accelerating the development of treatment and diagnostic opportunities for rare disease patients. The foundation focuses on science-driven public policy and works to improve the clinical trial process and regulatory environment. By bringing together patient advocates, industry leaders, and government agencies, the foundation aims to reduce the time and cost of drug development for rare conditions. Key initiatives include the Rare Disease Legislative Advocates (RDLA) and various programs focused on newborn screening and regulatory reform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kakkis EverLife Foundations.